| Gastrointestinal Therapeutics and Diagnostics (PHM046D) |
| Opdivo (nivolumab) |
|
GI cancer drug. It is a biological treatment for several types of cancer, including liver, colorectal, gastric, gastroesophageal junction and esophageal cancers. |
| Yervoy (ipilimumab) |
|
GI cancer drug. It is a biological treatment for several types of cancer, including a range of GI cancers (e.g., colorectal, liver, esophageal cancers). |
| Abraxane (paclitaxel) |
|
Chemotherapy, a mitotic inhibitor and anti-microtubule agent, blocks cell growth by stopping mitosis (cell division); indicated for the treatment of metastatic breast cancer, lung cancer and metastatic adenocarcinoma of the pancreas as first-line treatment in combination with gemcitabine. |
|
